CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Operating expenses: | ||||
| Research and development | $ 4,962 | $ 3,149 | $ 8,898 | $ 5,440 |
| General and administrative | 2,142 | 1,107 | 4,085 | 1,992 |
| Total operating expenses | 7,104 | 4,256 | 12,983 | 7,432 |
| Loss from operations | (7,104) | (4,256) | (12,983) | (7,432) |
| Other income (expense): | ||||
| Research and development incentives | (77) | 636 | 361 | 1,103 |
| Interest income | 664 | 10 | 891 | 40 |
| Change in fair value of warrant liability | (2) | (578) | (5,452) | (578) |
| Other income (expense), net | 58 | (472) | 678 | (1,345) |
| Total other income (expense), net | 643 | (404) | (3,522) | (780) |
| Net loss | (6,461) | (4,660) | (16,505) | (8,212) |
| Net loss attributable to common stockholders | $ (6,461) | $ (4,660) | $ (16,505) | $ (8,212) |
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | $ (0.26) | $ (0.94) | $ (1.11) | $ (1.65) |
| Weighted average common shares outstanding, basic and diluted (in shares) | 24,574,239 | 4,978,264 | 14,831,266 | 4,975,865 |